On Thursday, Iovance revealed updated clinical findings for lifileucel in conjunction with pembrolizumab as a treatment for frontline advanced melanoma, as well as implementation data, to be presented at the 2024 ASCO Annual Meeting.
Shares of Diodes Incorporated (NASDAQ:DIOD) fell sharply during Friday’s session after the company reported worse-than-expected quarterly financial results.…
Allegheny Health Network (AHN) Cancer Institute has become the first health care system in Western Pennsylvania to offer a first-of-its-kind cellular therapy recently approved by the U.S. Food and Drug Administration to